ImmunoPrecise Antibodies Ltd (NAS:IPA)
$ 0.76 -0.0333 (-4.2%) Market Cap: 20.75 Mil Enterprise Value: 29.23 Mil PE Ratio: 0 PB Ratio: 0.83 GF Score: 53/100

Immunoprecise Antibodies Ltd at Smallcap Discoveries Transcript

Jun 28, 2023 / 12:00PM GMT
Release Date Price: $2.94 (-2.49%)
Paul Andreola
SmallCap Discoveries - Moderator

Hey, listeners. It's Paul Andreola here. When I joined our community at SmallCap Discoveries, where we offer our members direct access to some of the best microcap investment opportunities available, our members are getting access to premium microcap financings, research reports and direct access to management. Sign up today at www.smallcapdiscoveries.com.

Trevor Treweeke
Capital Markets - Analyst

Hi, everyone. Welcome to the SmallCap Discoveries conference call. Today on our call, we have the CEO, Dr. Jennifer Bath from ImmunoPrecise Antibodies. ImmunoPrecise trades on the Nasdaq under the symbol IPA. The company currently trades at $3.18 with about 25 million shares outstanding or about a $72 million market cap.

I'd now like to hand it over to Paul Andreola.

Paul Andreola
SmallCap Discoveries - Moderator

Okay. Thanks, Trevor. Jennifer, welcome back, good to see you. It's been a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot